搜索临床试验以:Cholesterol 24S-hydroxylase inhibitor
总计69258个结果
-
LIB Therapeutics LLCMedpace, Inc.主动,不招人
-
University of Kansas Medical CenterNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)完全的
-
Obafemi Awolowo University Teaching HospitalUniversity Hospital Birmingham NHS Foundation Trust; Cures Within Reach完全的
-
University of Kansas Medical CenterNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)主动,不招人
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company撤销
-
Baylor College of MedicineMerck Sharp & Dohme LLC完全的
-
Innovent Biologics (Suzhou) Co. Ltd.完全的
-
Jiangxi Qingfeng Pharmaceutical Co. Ltd.完全的
-
Lars GullestadHelsinki University Central Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Sahlgrenska... 和其他合作者完全的
-
Mario Negri Institute for Pharmacological ResearchAssociazione Italiana per la Ricerca sul Cancro完全的
-
Institut de Recherches Internationales ServierADIR, a Servier Group company终止
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI)完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
University of ChicagoJohns Hopkins University主动,不招人
-
Kyoto UniversityJuntendo University; Yamaguchi University Hospital完全的
-
NewAmsterdam Pharma主动,不招人血脂异常 | 高胆固醇血症 | 家族性高胆固醇血症 | 动脉粥样硬化性心血管疾病 | 高胆固醇美国, 波兰, 丹麦, 捷克语, 中国, 荷兰, 日本, 乔治亚州
-
National Institute of Allergy and Infectious Diseases...完全的
-
The George Washington University Biostatistics...Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National...主动,不招人
-
NewAmsterdam Pharma完全的
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID); National Institute on Aging (NIA)完全的
-
Institut du Cancer de Montpellier - Val d'Aurelle终止
-
NSABP Foundation IncNational Cancer Institute (NCI)终止